Discover Mayo Clinic Platform Connect, a first-of-its-kind global health data network that connects healthcare organizations, researchers, and industry innovators to clean, curated, de-identified data. By enabling secure access to high-quality data at scale, this data network helps accelerate discovery, generate richer insights, and advance more equitable healthcare worldwide.

Meningiomas account for about 40% of all central nervous system tumors. A relatively new classification system can help focus clinicians’ attention on the best treatment[...]

By John Halamka, M.D. and Paul Cerrato — Most clinicians and patients are well aware of the challenges they have to deal with when interacting with the healthcare ecosystem. The right AI-enhanced systems can help ease the journey.

By John Halamka, M.D. and Paul Cerrato — Because the malignancy is relatively uncommon, it has received too little attention. Mayo Clinic researchers are doing their part to highlight its devastating effects and are using the latest deep learning models to detect it early on.

By John Halamka, M.D. and Paul Cerrato — Humility isn’t weakness—it’s a clinical strength. Learn how it helps physicians avoid overconfidence, reduce bias, and make better decisions.

By engaging with Mayo Clinic Platform, one Kansas-based health system transformed its safety culture and achieved measurable results.

Mayo Clinic Platform supports healthcare organizations with expert guidance and data-driven insights to address structural drivers of burnout and help teams restore time for patient care.

By John Halamka and Paul Cerrato — Chatbots are offering a quick way for patients to collect and access their records, but the tools they are using are not always secure, or accurate.

By John Halamka and Paul Cerrato — The best medicine combines high tech and high touch approaches to patient care.

By John Halamka and Paul Cerrato—The AI agent offers several labor-saving features but also poses several serious risks.

By John Halamka and Paul Cerrato—Genomics, transcriptomics, proteomics, and metabolomics are increasingly helping to uncover the molecular mechanisms underlying many diseases.

By John Halamka and Paul Cerrato—Pancreatic cancer remains one of the most life-threatening malignancies because it is so difficult to detect in its earliest, most manageable stage. Recent developments in AI, however, suggest it may be possible to improve the diagnostic process.